glp 1 inhibitors brand names Market Overview: GLP-1 Agonists and the Obesity Market | Blog GLP-1 medicines: What are GLP-1
Description
Obesity affects 42% of adults in the United States and is strongly associated with major cardiovascular disease risk factors, including high blood pressure, abnormal cholesterol levels, and insulin resistance, making effective obesity treatment a critical public health priority.
The experimental data indicate GLP-1 and its analogs to have direct effects on the cardiovascular system, in addition to their classic glucoregulatory actions
No known side effects.
Results Unimolecular peptides have been developed for the treatment of obesity and type-2 diabetes
Some pizzerias are experimenting with protein-infused dough and high-protein LTOs to cater to the 12% of Americans reporting use of GLP-1 drugs.
Dealing with a yeast infection
